Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Mobile and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:S13–24.
Culley MK, Chan SY. Endothelial senescence: a brand new age in pulmonary hypertension. Circ Res. 2022;130:928–41.
Boucherat O, Agrawal V, Lawrie A, Bonnet S. The newest in animal fashions of pulmonary hypertension and proper ventricular failure. Circ Res. 2022;130:1466–86.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, ESC/ERS Scientific Doc Group, et al. 2022 ESC/ERS tips for the prognosis and remedy of pulmonary hypertension. Eur Coronary heart J. 2022;43:3618–731.
Zhang J, Zhou J, Cai L, Lu Y, Wang T, Zhu L, et al. Extracellular calcium-sensing receptor is vital in hypoxic pulmonary vasoconstriction. Antioxid Redox Sign. 2012;17:471–84.
Xiao R, Luo S, Zhang T, Lv Y, Wang T, Zhang J, et al. Peptide blocking self-polymerization of extracellular calcium-sensing receptor attenuates hypoxia-induced pulmonary hypertension. Hypertension. 2021;78:1605–16.
Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, et al. Hypoxia triggers subcellular compartmental redox signaling in vascular easy muscle cells. Circ Res. 2010;106:526–35.
Desireddi JR, Farrow KN, Marks JD, Waypa GB, Schumacker PT. Hypoxia will increase ROS signaling and cytosolic Ca2+ in pulmonary artery easy muscle cells of mouse lungs slices. Antioxid Redox Sign. 2010;12:595–602.
Pak O, Scheibe S, Esfandiary A, Gierhardt M, Sydykov A, Logan A et al. Impression of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension. Eur Respir J. 2018:1701024.
Ahmed MN, Zhang Y, Codipilly C, Zaghloul N, Patel D, Wolin M, et al. Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension. Mol Med. 2012;18:38–46.
Adesina SE, Kang BY, Bijli KM, Ma J, Cheng J, Murphy TC, et al. Focusing on mitochondrial reactive oxygen species to modulate hypoxia-induced pulmonary hypertension. Free Radic Biol Med. 2015;87:36–47.
Kang Y, Zhang G, Huang EC, Huang J, Cai J, Cai L, et al. Sulforaphane prevents proper ventricular harm and reduces pulmonary vascular reworking in pulmonary arterial hypertension. Am J Physiol Coronary heart Circ Physiol. 2020;318:H853–66.
Budas GR, Boehm M, Kojonazarov B, Viswanathan G, Tian X, Veeroju S, et al. ASK1 inhibition halts illness development in preclinical fashions of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;197:373–85.
Zhang R, Fan Ok, Yan X. Nanozymes: created by studying from nature. Sci China Life Sci. 2020;63:1183–200.
Wu J, Wang X, Wang Q, Lou Z, Li S, Zhu Y, et al. Nanomaterials with enzyme-like traits (nanozymes): next-generation synthetic enzymes (II). Chem Soc Rev. 2019;48:1004–76.
Ai Y, Hu Z, Liang X, Solar H, Xin H, Liang Q. Latest advances in nanozymes: from issues to bioapplications. Adv Funct Mater. 2021;32:2110432.
Zhang C, Wang X, Du J, Gu Z, Zhao Y. Reactive oxygen species-regulating methods based mostly on nanomaterials for illness remedy. Adv Sci. 2021;8:2002797.
Chung D. Nanoparticles have well being advantages too. New Sci. 2003;179:2410–6.
Tarnuzzer RW, Colon J, Patil S, Seal S. Emptiness engineered ceria nanostructures for defense from radiation-induced mobile harm. Nano Lett. 2005;5:2573–7.
Niu J, Azfer A, Rogers LM, Wang X, Kolattukudy PE. Cardioprotective results of cerium oxide nanoparticles in a transgenic murine mannequin of cardiomyopathy. Cardiovasc Res. 2007;73:549–59.
Das S, Dowding JM, Klump KE, McGinnis JF, Self W, Seal S. Cerium oxide nanoparticles: functions and prospects in nanomedicine. Nanomed (Lond). 2013;8:1483–508.
Arya A, Sethy NK, Singh SK, Das M, Bhargava Ok. Cerium oxide nanoparticles shield rodent lungs from hypobaric hypoxia-induced oxidative stress and irritation. Int J Nanomed. 2013;8:4507–20.
Gubernatorova EO, Liu X, Othman A, Muraoka WT, Koroleva EP, Andreescu S et al. Europium-doped cerium oxide nanoparticles restrict reactive oxygen species formation and ameliorate intestinal ischemia-reperfusion harm. Adv Healthc Mater. 2017;6.
Ni D, Wei H, Chen W, Bao Q, Rosenkrans ZT, Barnhart TE, et al. Ceria nanoparticles meet hepatic ischemia-reperfusion harm: the right imperfection. Adv Mater. 2019;31:e1902956.
Li X, Han Z, Wang T, Ma C, Li H, Lei H, et al. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke. Biomaterials. 2022;291:121904.
Dong S, Dong Y, Jia T, Liu S, Liu J, Yang D, He F, Gai S, Yang P, Lin J. GSH-depleted nanozymes with hyperthermia-enhanced twin enzyme-mimic actions for tumor nanocatalytic remedy. Adv Mater. 2020;32:e2002439.
Liu J, Liu C, Tang J, Chen Q, Yu Y, Dong Y, Hao J, Wu W. Synergistic cerium oxide nanozymes: focusing on DNA harm and assuaging tumor hypoxia for improved NSCLC radiotherapy effectivity. J Nanobiotechnol. 2024;22:25.
Kwon HJ, Kim D, Web optimization Ok, Kim YG, Han SI, Kang T, et al. Ceria nanoparticle methods for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson’s illness. Angew Chem Int Ed Engl. 2018;57:9408–12.
Li M, Shi P, Xu C, Ren J, Qu X. Cerium oxide caged steel chelator: anti-aggregation and anti-oxidation built-in H2O2-responsive managed drug launch for potential Alzheimer’s illness remedy. Chem Sci. 2013;4:2536–42.
Amin KA, Hassan MS, Awad el-ST, Hashem KS. The protecting results of cerium oxide nanoparticles in opposition to hepatic oxidative harm induced by monocrotaline. Int J Nanomed. 2011;6:143–9.
Kolli MB, Manne NDPK, Para R, Nalabotu SK, Nandyala G, Shokuhfar T, et al. Cerium oxide nanoparticles attenuate monocrotaline induced proper ventricular hypertrophy following pulmonary arterial hypertension. Biomaterials. 2014;35:9951–62.
Nassar SZ, Hassaan PS, Abdelmonsif DA, ElAchy SN. Cardioprotective impact of cerium oxide nanoparticles in monocrotaline rat mannequin of pulmonary hypertension: a attainable implication of endothelin-1. Life Sci. 2018;201:89–101.
Heckert EG, Karakoti AS, Seal S, Self WT. The position of cerium redox state within the SOD mimetic exercise of nanoceria. Biomaterials. 2008;29:2705–9.
Celardo I, Pedersen JZ, Traversa E, Ghibelli L. Pharmacological potential of cerium oxide nanoparticles. Nanoscale. 2011;3:1411–20.
Li M, Liu J, Shi L, Zhou C, Zou M, Fu D, et al. Gold nanoparticles-embedded ceria with enhanced antioxidant actions for treating inflammatory bowel illness. Bioact Mater. 2023;25:95–106.
Jian B, Yang S, Chen D, Zou L, Chatham JC, Chaudry I, et al. Growing older influences cardiac mitochondrial gene expression and cardiovascular operate following hemorrhage harm. Mol Med. 2011;17:542–9.
Lyon AR, Joudrey PJ, Jin D, Nass RD, Aon MA, O’Rourke B, et al. Optical imaging of mitochondrial operate uncovers actively propagating waves of mitochondrial membrane potential collapse throughout intact coronary heart. J Mol Cell Cardiol. 2010;49:565–75.
Li J, Tune S, Lengthy Y, Wu L, Wang X, Xing Y et al. Investigating the hybrid-structure-effect of CeO2-encapsulated au nanostructures on the switch coupling of nitrobenzene. Adv Mater. 2018;30.
Miao Z, Jiang S, Ding M, Solar S, Ma Y, Younis MR, et al. Ultrasmall rhodium nanozyme with RONS scavenging and photothermal actions for anti-inflammation and antitumor theranostics of colon ailments. Nano Lett. 2020;20:3079–89.
Zeng X, Zhu L, Xiao R, Liu B, Solar M, Liu F, et al. Hypoxia-induced mitogenic issue acts as a nonclassical ligand of calcium-sensing receptor, therapeutically exploitable for intermittent hypoxia-induced pulmonary hypertension. Hypertension. 2017;69:844–54.
Ziegelstein RC, Xiong Y, He C, Hu Q. Expression of a purposeful extracellular calcium-sensing receptor in human aortic endothelial cells. Biochem Biophys Res Commun. 2006;342:153–63.
Zhu L, Liu F, Hao Q, Feng T, Chen Z, Luo S, et al. Dietary geranylgeranyl pyrophosphate counteracts the advantages of statin remedy in experimental pulmonary hypertension. Circulation. 2021;143:1775–92.
Xiao R, Liu J, Luo S, Yu Z, Zhang J, Lv Y, et al. Orally-administrated mitochondria attenuate pulmonary hypertension with assistance from erythrocytes as carriers. Clin Transl Med. 2022;12:e1033.
Yamamura A, Guo Q, Yamamura H, Zimnicka AM, Pohl NM, Smith KA, et al. Enhanced Ca2+-sensing receptor operate in idiopathic pulmonary arterial hypertension. Circ Res. 2012;111:469–81.
Casals E, Zeng M, Parra-Robert M, Fernández-Varo G, Morales-Ruiz M, Jiménez W, et al. Cerium oxide nanoparticles: advances in biodistribution, toxicity, and preclinical exploration. Small. 2020;16:e1907322.
Yuan MJ, Li Q, Gao Y, He C, Adli M, Wu CZ, et al. Tunable structured steel oxides for biocatalytic therapeutics. Adv Funct Mater. 2023;33(40):2304271.
Sheng J, Wu Y, Ding H, Feng Ok, Shen Y, Zhang Y, et al. Multienzyme-like nanozymes: regulation, rational design, and utility. Adv Mater. 2024;36:e2211210.
Buzea C, Pacheco II, Robbie Ok. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:MR17–71.
Win KY, Feng SS. Results of particle measurement and floor coating on mobile uptake of polymeric nanoparticles for oral supply of anticancer medicine. Biomaterials. 2005;26:2713–22.
Lu F, Wu SH, Hung Y, Mou CY. Measurement impact on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small. 2009;5:1408–13.
Chithrani BD, Chan WC. Elucidating the mechanism of mobile uptake and elimination of protein-coated gold nanoparticles of various shapes and sizes. Nano Lett. 2007;7:1542–50.
Ding L, Yao C, Yin X, Li C, Huang Y, Wu M, et al. Measurement, form, and protein corona decide mobile uptake and elimination mechanisms of gold nanoparticles. Small. 2018;14:e1801451.
Manzanares D, Ceña V, Endocytosis. The nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics. 2020;12:371.
Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, et al. Cerium oxide nanoparticle-induced pulmonary irritation and alveolar macrophage purposeful change in rats. Nanotoxicology. 2011;5:312–25.
Ma J, Bishoff B, Mercer RR, Barger M, Schwegler-Berry D, Castranova V. Position of epithelial-mesenchymal transition (EMT) and fibroblast operate in cerium oxide nanoparticles-induced lung fibrosis. Toxicol Appl Pharmacol. 2017;323:16–25.
Dowding JM, Das S, Kumar A, Dosani T, McCormack R, Gupta A, et al. Mobile interplay and toxicity rely upon physicochemical properties and floor modification of redox-active nanomaterials. ACS Nano. 2013;7:4855–68.
Rogers S, Rice KM, Manne ND, Shokuhfar T, He Ok, Selvaraj V, et al. Cerium oxide nanoparticle aggregates have an effect on stress response and performance in Caenorhabditis elegans. SAGE Open Med. 2015;3:2050312115575387.
Feliu N, Docter D, Heine M, Del Pino P, Ashraf S, Kolosnjaj-Tabi J, et al. In vivo degeneration and the destiny of inorganic nanoparticles. Chem Soc Rev. 2016;45:2440–57.
Newman SP. Aerosol deposition issues in inhalation remedy. Chest. 1985;88:S152–60.
Johnson MA, Newman SP, Bloom R, Talaee N, Clarke SW. Supply of albuterol and ipratropium bromide from two nebulizer methods in power secure bronchial asthma. Efficacy and pulmonary deposition. Chest. 1989;96:6–10.
Mashat M, Clark BJ, Assi KH, Chrystyn H. In vitro aerodynamic characterization of the dose emitted throughout nebulization of tobramycin excessive power resolution by novel and jet nebulizer supply methods. Pulm Pharmacol Ther. 2016;37:37–42.
